Investors sold shares of Monsanto Company (NYSE:MON) on strength during trading hours on Friday following insider selling activity. $23.85 million flowed into the stock on the tick-up and $89.73 million flowed out of the stock on the tick-down, for a money net flow of $65.88 million out of the stock. Of all stocks tracked, Monsanto Company had the 0th highest net out-flow for the day. Monsanto Company traded up $0.29 for the day and closed at $107.62Specifically, EVP Kerry J. Preete sold 2,745 shares of the stock in a transaction on Thursday, November 17th. The stock was sold at an average price of $100.96, for a total transaction of $277,135.20. Following the sale, the executive vice president now owns 50,056 shares in the company, valued at $5,053,653.76. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Steven Mizell sold 2,525 shares of the stock in a transaction on Tuesday, January 10th. The stock was sold at an average price of $108.56, for a total value of $274,114.00. Following the sale, the executive vice president now owns 43,711 shares in the company, valued at approximately $4,745,266.16. The disclosure for this sale can be found here. Insiders own 0.79% of the company’s stock.

MON has been the topic of several research analyst reports. Sanford C. Bernstein upgraded Monsanto Company from an “underperform” rating to a “market perform” rating and increased their target price for the stock from $82.81 to $105.00 in a report on Monday, September 26th. J P Morgan Chase & Co set a $128.00 price target on Monsanto Company and gave the company a “buy” rating in a report on Thursday, October 6th. Deutsche Bank AG reiterated a “buy” rating on shares of Monsanto Company in a report on Thursday, October 6th. Zacks Investment Research cut Monsanto Company from a “hold” rating to a “strong sell” rating in a report on Friday, October 7th. Finally, CLSA upgraded Monsanto Company from an “underperform” rating to an “outperform” rating in a report on Friday, January 6th. They noted that the move was a valuation call. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating and seventeen have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $114.46.

The company has a 50-day moving average of $105.26 and a 200 day moving average of $103.92. The firm has a market capitalization of $47.20 billion, a P/E ratio of 29.51 and a beta of 1.01.

Monsanto Company (NYSE:MON) last posted its quarterly earnings results on Thursday, January 5th. The company reported $0.21 earnings per share for the quarter, topping analysts’ consensus estimates of $0.01 by $0.20. Monsanto Company had a return on equity of 47.05% and a net margin of 11.61%. The business had revenue of $2.22 billion for the quarter. During the same period last year, the company posted ($0.11) earnings per share. The firm’s quarterly revenue was up 19.4% compared to the same quarter last year. Analysts anticipate that Monsanto Company will post $4.73 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, January 27th. Investors of record on Friday, January 6th will be paid a dividend of $0.54 per share. This represents a $2.16 dividend on an annualized basis and a yield of 2.01%. The ex-dividend date of this dividend is Wednesday, January 4th. Monsanto Company’s dividend payout ratio (DPR) is currently 58.86%.

Hedge funds and other institutional investors have recently bought and sold shares of the company. HL Financial Services LLC increased its position in Monsanto Company by 49.1% in the second quarter. HL Financial Services LLC now owns 8,525 shares of the company’s stock worth $882,000 after buying an additional 2,807 shares during the period. Rehmann Capital Advisory Group increased its position in Monsanto Company by 13.4% in the second quarter. Rehmann Capital Advisory Group now owns 8,087 shares of the company’s stock worth $836,000 after buying an additional 953 shares during the period. Callahan Advisors LLC increased its position in Monsanto Company by 2.6% in the second quarter. Callahan Advisors LLC now owns 8,547 shares of the company’s stock worth $884,000 after buying an additional 217 shares during the period. Destination Wealth Management increased its position in Monsanto Company by 42.1% in the second quarter. Destination Wealth Management now owns 72,219 shares of the company’s stock worth $7,468,000 after buying an additional 21,380 shares during the period. Finally, Albion Financial Group UT purchased a new position in Monsanto Company during the second quarter worth $210,000. 73.70% of the stock is currently owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: This piece was first published by Daily Political and is the propert of of Daily Political. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright law. The original version of this piece can be read at http://www.dailypolitical.com/2017/01/13/investors-sell-monsanto-company-mon-on-strength-following-insider-selling.html.

Monsanto Company Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

5 Day Chart for NYSE:MON

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.